Unichem Laboratories rises 2% on USFDA approval

Share price of Unichem Laboratories rose 2.6 percent intraday on after the company received USFDA approval for Allopurinol tablets.

The company has received ANDA approval for its Allopurinol Tablets, USP 100 mg and 300 mg from the United States Food and Drug Administration (USFDA) to market a generic version of ZYLOPRIM (allopurinol) tablet, company said in a release.

The product will be commercialized from company’s Ghaziabad plant.

At 1500 hours, Unichem Laboratories was quoting at Rs 206.15, up Rs 3.75, or 1.85 percent on the BSE.

Sign Up for Our Newsletters

Get notified of the best deals on our WordPress themes.

You May Also Like

ICI reports offer insights into the characteristics of IRA investors

Posted by Jon Vogler, Senior Analyst, Retirement Research on Oct 5, 2018,…

New tax reform bill includes retirement provisions

Posted by Jon Vogler, Senior Analyst, Retirement Research on Sep 20, 2018,…

Opinion | The Secret Lives of Central Bankers

A few years ago, a senior Japanese central banker let me in…

What may LIBOR’s phase-out mean for investors?

Posted by Justin Mandeville, Portfolio Manager and Jacob Habibi, Senior Analyst on…